
Social media users and health experts raise fresh concerns around kratom-containing drinks like Feel Free
Feel Free is sold at many gas stations and retailers across the United States. That is where influencer Misha Brown first heard of the product. On July 25, he posted a now-viral video, recounting how a teenage boy tried stealing his wallet outside a gas station after he refused to purchase a Feel Free tonic for the boy.
After Brown informed the cashier about what had just transpired, she pointed to Feel Free and told him that people were coming in multiple times a day to purchase the product. 'It's so addictive and people lose their minds,' Brown recalled the attendant telling him.
His video now has over 23 millions views and has sparked a wave of media attention. Social media users and experts alike are warning people about the addictive effects of products containing kratom, NBC News reported.
Launched in 2020, the drink is advertised online as for 'whenever you want a mood lift, a caffeine-free energy boost, or a little extra focus.'
Notably, the ingredients in Feel Free's Classic tonic include kratom, a plant native to Southeast Asia that's known for its stimulant and opioid-like effects.
Concerns around the ingredient and its effects are not new. Scott Gottlieb, then commissioner of the Food and Drug Administration (FDA), said in 2018 that evidence pointed to the presence of opioid compounds in kratom, that it acts in the brain the same way as opioids do, and that it comes with 'potential for abuse.' It is currently banned in five states, according to a report from the Congressional Research Service.
On Reddit, a group dedicated to quitting Feel Free now has over 5,000 followers. Users have shared experiences that include skin infections, seizures, and stints in rehab. 'These drinks are insane and not only leave you financially ruined but also physically and mentally,' one user wrote in a recent post.
Botanic Tonics, the company behind Feel Free, agreed to pay $8.75 million to settle a 2023 class action lawsuit that claimed it failed to warn consumers about the dangers of kratom.
Without admitting wrongdoing, the company has since updated its labels to warn that the drink may in fact be habit-forming. People with a history of substance abuse are advised to avoid using it.
Fast Company has contacted Botanic Tonics for comment.
In July, the FDA announced that it is recommending scheduling action to control products containing 7-OH, a byproduct of the kratom plant. This recommendation does not apply to natural kratom leaf products.
Following the announcement, Feel Free wrote that its Feel Free Classic tonic contains only natural leaf kratom, meaning the FDA's proposed action would not affect the drink. '7-OH products bear absolutely no resemblance to the natural leaf kratom products that are used by more than 23 million Americans,' the company states.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Verge
39 minutes ago
- The Verge
RFK Jr.: ‘Trusting the experts is not science.'
Posted Aug 12, 2025 at 12:07 PM UTC Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates. Jess Weatherbed Posts from this author will be added to your daily email digest and your homepage feed. See All by Jess Weatherbed Posts from this topic will be added to your daily email digest and your homepage feed. See All Health Posts from this topic will be added to your daily email digest and your homepage feed. See All News Posts from this topic will be added to your daily email digest and your homepage feed. See All Policy Posts from this topic will be added to your daily email digest and your homepage feed. See All Science
Yahoo
an hour ago
- Yahoo
Eat this summer veggie low in calories to help with bloating
Summer 2025 might be winding down in a couple of weeks, but your summer nutrition doesn't have to. If you've been feeling a little backed up, there's one particular low-calorie vegetable that can help you beat the bloat: zucchini. According to NBC's nutrition and lifestyle expert Joy Bauer, zucchini 'wins because it checks a lot of boxes.' 'It's naturally low in calories,' she said of the popular summertime squash during a recent TODAY Show segment. 'And it's filled with water, so that alone helps to flush out extra bloat,' Bauer said. When you're struggling with constipation, it's important to ensure you're eating a fiber-rich diet and drinking plenty of water, per the Mayo Clinic. While there are certainly many other popular veggies besides zucchini that are hydrating and good sources of fiber, such as corn and mushrooms, the typically oblong-shaped vegetable is the least likely to irritate sensitive stomachs that suffer from gastrointestinal conditions such as irritable bowel syndrome, Bauer said. This is because zucchinis are low in fermentable carbohydrates — a type of carbohydrate that, when broken down by the gut, often produces gas. Therefore, they aren't going to 'cause any digestive drama,' she shared, adding: 'It's basically your belly's best friend when you're feeling bloated.' Just one average-sized zucchini, around one cup, contains approximately 2 grams of fiber, reports Healthline. But zucchinis aren't the only summer squash with impressive gut-enriching qualities, other dietitians told the outlet. Its vegetable relative, the yellow summer squash, also contains important vitamins and minerals — vitamin C and potassium, which your body requires to stay hydrated and running smoothly.


Bloomberg
4 hours ago
- Bloomberg
Eli Lilly, Pfizer Seek Spot in China Private Insurance Catalog
A clutch of Western drugmakers are looking to boost sales of their most innovative and expensive medicines in China, the world's second-largest pharmaceuticals market, by trying to get their treatments included in Beijing's new catalog for commercial health insurance. Eli Lilly & Co., Novo Nordisk A/S and Pfizer Inc. are among those who have applied for a place in the catalog, according to documents released Tuesday by the National Health Security Administration. The idea of the list, incorporating innovative drugs that are far too expensive to be covered by the state insurance program but recommended for reimbursement by private health insurers, was first touted this year.